Found "AI": 1,179 results
Sort by
Sort by
Last updated
Thailand’s health financing resilience during COVID-19: leveraging universal health coverage to tackle the pandemic
Abstract
Background
The COVID-19 pandemic constituted a public health emergency in Thailand from March 2020 to October 2022, testing the resilience of the health financing system. This study establishes an analytical framework to examine Thailand’s public health financing arrangements and their su
Final Report: Understanding the determinants and dynamics of access to maternal, newborn and child health care for migrants in Thailand along the Thai-Myanmar border
Undocumented pregnant women migrants and their young children are disproportionately affected by displacement and health system constraints. In Thailand, chronic gaps in financing and manpower resources challenge the sustainability of border health facilities to provide services to migrants. Kanchan
Thailand's AMR Strategy: Insights from the 5th National Forum on AMR
Thailand's National Forum on Antimicrobial Resistance (AMR), held every two years, serves as a platform to share knowledge and reinforce the importance of AMR as a global public health threat. Yet AMR rarely commands public attention, compared to non-communicable diseases, despite being associated w
Introduction of early health technology assessment for innovators, clinicians, and funders
Abstract
Health technology faces rising costs, system complexities, and gaps between development and coverage policies, limiting translation into practice. Traditional health technology assessment (HTA) evaluates technologies at late stages, providing little support if a technology fails to secur
Co-creating a process for integrating regulatory approval of late- stage clinical research into the Thailand’s Universal Benefit Package through Action Research
The research and development of new medicines is a lengthy and sequential process that spans more than a decade, culminating in regulatory approval based on evidence of quality, safety, and efficacy from clinical trial data. In Thailand, it takes nearly an additional decade for new medicines to be included in the Thailand National List of Essential
Can AI Really Help Us Prevent Diabetes and Hypertension in Thailand?
Non-communicable diseases (NCDs) are often called “silent killers”, but there is nothing silent about their impact. They remain one of the hardest public health battles to win. According to the World Health Organisation (WHO), they cause 43 million deaths worldwide and account for 75% of non-pandemi
From Potential to Practice: AI for Diabetes and Hypertension Prevention in Thailand
Background & RationaleNon-communicable diseases (NCDs) are the leading cause of death worldwide, responsible for 43 million deaths annually and accounting for 75% of all non-pandemic-related mortality globally [1]. Cardiovascular disease, diabetes, cancer, and chronic respiratory conditions drive this burden, yet most health systems remain orie
10 / Page